Overview
Public Biotech
Clinical-stage biopharma developing psilocybin-assisted therapy (PSX-001) for generalized anxiety disorder and cannabinoid combinations for sleep apnea. Positive Phase 2 results in 2025 for both programs.
Visit WebsiteWilmington, DE
$75M
Market Cap
2015
Founded
0
Open Roles
Open Positions
No open positions at this time
Clinical Pipeline
No clinical trials on record